Ethical Issues with Newborn Screening in the Genomics Era

Overview

Journal Annu Rev Genomics Hum Genet

Publisher Annual Reviews

Specialty Genetics

Date 2012 May 8

PMID 22559326

Citations 51

Authors

Beth A Tarini

Aaron J Goldenberg

Affiliations

Soon will be listed here.

Abstract

Continued technological advances have made the prospect of routine whole-genome sequencing (WGS) imminent. To date, much of the discussion about WGS has focused on its application and use in clinical medicine. Relatively little attention has been paid to the potential integration of WGS into newborn screening programs. Given the structure and scope of these programs, it is possible that the early applications of WGS will occur in state-run newborn screening programs. Assessment of the pressing ethical issues currently facing the newborn screening community will provide insight into the challenges that lie ahead in the genomics era.

Citing Articles

Newborn Screening for Gaucher Disease: Parental Stress and Psychological Burden.

Cazzorla C, Gragnaniello V, Gaiga G, Gueraldi D, Puma A, Loro C Int J Neonatal Screen. 2025; 11(1).

PMID: 39982348 PMC: 11843941. DOI: 10.3390/ijns11010014.

Targeted gene sequencing and hearing follow-up in 7501 newborns reveals an improved strategy for newborn hearing screening.

Hao C, Hu X, Guo R, Qi Z, Jin F, Zhang X Eur J Hum Genet. 2024; .

PMID: 39443691 DOI: 10.1038/s41431-024-01711-x.

Charting the Ethical Frontier in Newborn Screening Research: Insights from the NBSTRN ELSI Researcher Needs Survey.

Unnikumaran Y, Lietsch M, Brower A Int J Neonatal Screen. 2024; 10(3).

PMID: 39311366 PMC: 11417897. DOI: 10.3390/ijns10030064.

Exploratory Untargeted Metabolomics of Dried Blood Spot Samples from Newborns with Maple Syrup Urine Disease.

Alotaibi A, AlMalki R, Al Mogren M, Sebaa R, Alanazi M, Jacob M Int J Mol Sci. 2024; 25(11).

PMID: 38891907 PMC: 11171634. DOI: 10.3390/ijms25115720.

Newborn Screening for Li-Fraumeni Syndrome: Patient Perspectives.

Beigh M, Vagher J, Codden R, Maese L, Cook S, Gammon A Res Sq. 2024; .

PMID: 38798617 PMC: 11118696. DOI: 10.21203/rs.3.rs-4351728/v1.

References

Alexander D, van Dyck P . A vision of the future of newborn screening. Pediatrics. 2006; 117(5 Pt 2):S350-4. DOI: 10.1542/peds.2005-2633O. View

Kohane I, Masys D, Altman R . The incidentalome: a threat to genomic medicine. JAMA. 2006; 296(2):212-5. DOI: 10.1001/jama.296.2.212. View

Kraszewski J, Burke T, Rosenbaum S . Legal issues in newborn screening: implications for public health practice and policy. Public Health Rep. 2006; 121(1):92-4. PMC: 1497802. DOI: 10.1177/003335490612100116. View

Lanie A, Jayaratne T, Sheldon J, Kardia S, Anderson E, Feldbaum M . Exploring the public understanding of basic genetic concepts. J Genet Couns. 2009; 13(4):305-20. PMC: 3832055. DOI: 10.1023/b:jogc.0000035524.66944.6d. View

Hoff T, Ayoob M, Therrell B . Long-term follow-up data collection and use in state newborn screening programs. Arch Pediatr Adolesc Med. 2007; 161(10):994-1000. DOI: 10.1001/archpedi.161.10.994. View

Tarini B, Christakis D, Welch H . State newborn screening in the tandem mass spectrometry era: more tests, more false-positive results. Pediatrics. 2006; 118(2):448-56. DOI: 10.1542/peds.2005-2026. View

Faulkner L, Feuchtbaum L, Graham S, Bolstad J, Cunningham G . The newborn screening educational gap: what prenatal care providers do compared with what is expected. Am J Obstet Gynecol. 2006; 194(1):131-7. DOI: 10.1016/j.ajog.2005.05.075. View

Waisbren S, Albers S, Amato S, Ampola M, Brewster T, Demmer L . Effect of expanded newborn screening for biochemical genetic disorders on child outcomes and parental stress. JAMA. 2003; 290(19):2564-72. DOI: 10.1001/jama.290.19.2564. View

Feuchtbaum L, Cunningham G, Sciortino S . Questioning the Need for Informed Consent: A Case Study of California's Experience with a Pilot Newborn Screening Research Project. J Empir Res Hum Res Ethics. 2009; 2(3):3-14. DOI: 10.1525/jer.2007.2.3.3. View

10.

Gurian E, Kinnamon D, Henry J, Waisbren S . Expanded newborn screening for biochemical disorders: the effect of a false-positive result. Pediatrics. 2006; 117(6):1915-21. DOI: 10.1542/peds.2005-2294. View

11.

Stadler S, Polanetz R, Maier E, Heidenreich S, Niederer B, Mayerhofer P . Newborn screening for 3-methylcrotonyl-CoA carboxylase deficiency: population heterogeneity of MCCA and MCCB mutations and impact on risk assessment. Hum Mutat. 2006; 27(8):748-59. DOI: 10.1002/humu.20349. View

12.

Stoddard J, Farrell P . State-to-state variations in newborn screening policies. Arch Pediatr Adolesc Med. 1997; 151(6):561-4. DOI: 10.1001/archpedi.1997.02170430027005. View

13.

Kemper A, Fant K, Clark S . Informing parents about newborn screening. Public Health Nurs. 2005; 22(4):332-8. DOI: 10.1111/j.0737-1209.2005.220408.x. View

14.

Lenke R, Levy H . Maternal phenylketonuria and hyperphenylalaninemia. An international survey of the outcome of untreated and treated pregnancies. N Engl J Med. 1980; 303(21):1202-8. DOI: 10.1056/NEJM198011203032104. View

15.

Kim S, Lloyd-Puryear M, Tonniges T . Examination of the communication practices between state newborn screening programs and the medical home. Pediatrics. 2003; 111(2):E120-6. DOI: 10.1542/peds.111.2.e120. View

16.

Clayton E . Talking with parents before newborn screening. J Pediatr. 2005; 147(3 Suppl):S26-9. DOI: 10.1016/j.jpeds.2005.08.001. View

17.

McKie J, Richardson J . The rule of rescue. Soc Sci Med. 2003; 56(12):2407-19. DOI: 10.1016/s0277-9536(02)00244-7. View

18.

Davis T, Humiston S, Arnold C, Bocchini Jr J, Bass 3rd P, Kennen E . Recommendations for effective newborn screening communication: results of focus groups with parents, providers, and experts. Pediatrics. 2006; 117(5 Pt 2):S326-40. DOI: 10.1542/peds.2005-2633M. View

19.

Kai J, Ulph F, Cullinan T, Qureshi N . Communication of carrier status information following universal newborn screening for sickle cell disorders and cystic fibrosis: qualitative study of experience and practice. Health Technol Assess. 2009; 13(57):1-82, iii. DOI: 10.3310/hta13570. View

20.

Lipstein E, Perrin J, Waisbren S, Prosser L . Impact of false-positive newborn metabolic screening results on early health care utilization. Genet Med. 2009; 11(10):716-21. PMC: 2773165. DOI: 10.1097/GIM.0b013e3181b3a61e. View